Cargando…

Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France

BACKGROUND: To identify demographic and clinical factors associated with psychological and behavioral functioning (PBF) in people with type 2 diabetes living in France. METHODS: In March 2002, approximately 10,000 adults, who had been reimbursed for at least one hypoglycemic treatment or insulin dos...

Descripción completa

Detalles Bibliográficos
Autores principales: Boini, Stephanie, Erpelding, Marie-Line, Fagot-Campagna, Anne, Mesbah, Mounir, Chwalow, Judith, Penfornis, Alfred, Coliche, Vincent, Mollet, Etienne, Meadows, Keith, Briançon, Serge
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991282/
https://www.ncbi.nlm.nih.gov/pubmed/21044345
http://dx.doi.org/10.1186/1477-7525-8-124
_version_ 1782192579848175616
author Boini, Stephanie
Erpelding, Marie-Line
Fagot-Campagna, Anne
Mesbah, Mounir
Chwalow, Judith
Penfornis, Alfred
Coliche, Vincent
Mollet, Etienne
Meadows, Keith
Briançon, Serge
author_facet Boini, Stephanie
Erpelding, Marie-Line
Fagot-Campagna, Anne
Mesbah, Mounir
Chwalow, Judith
Penfornis, Alfred
Coliche, Vincent
Mollet, Etienne
Meadows, Keith
Briançon, Serge
author_sort Boini, Stephanie
collection PubMed
description BACKGROUND: To identify demographic and clinical factors associated with psychological and behavioral functioning (PBF) in people with type 2 diabetes living in France. METHODS: In March 2002, approximately 10,000 adults, who had been reimbursed for at least one hypoglycemic treatment or insulin dose during the last quarter of 2001, received a questionnaire about their health status and PBF (3,646 responders). For this analysis, the 3,090 persons with type 2 diabetes, aged 18-85 years old were selected. PBF was measured with the adapted version of the Diabetes Health Profile for people with type 2 diabetes. This permitted the calculation of three functional scores - psychological distress (PD), barriers to activity (BA), and disinhibited eating (DE) - from 0 (worst) to 100 (best). RESULTS: Major negative associations were observed with PBF for microvascular complications (a difference of 6.7 in the BA score between persons with and without microvascular complications) and severe hypoglycemia (difference of 7.9 in the BA score), insulin treatment (-8.5 & -9.5 in the PD & BA scores respectively, as compared to treatment with oral hypoglycemic agents), non-adherence to treatment (-12.3 in the DE score for persons forgetting their weekly treatment), increasing weight (-8.5 & -9.7 in the PD & DE scores respectively, as compared to stable weight), at least one psychiatrist visit in 2001 (-8.9 in the DE score), and universal medical insurance coverage (-7.9 in the PD score) (due to low income). CONCLUSION: Prevention and management of microvascular complications or adherence to treatment (modifiable factors) could be essential to preserving or improving PBF among people with type 2 diabetes. A specific approach to type 2 diabetes management may be required in groups with a low socioeconomic profile (particularly people with universal medical insurance coverage), or other non modifiable factors.
format Text
id pubmed-2991282
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29912822010-11-25 Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France Boini, Stephanie Erpelding, Marie-Line Fagot-Campagna, Anne Mesbah, Mounir Chwalow, Judith Penfornis, Alfred Coliche, Vincent Mollet, Etienne Meadows, Keith Briançon, Serge Health Qual Life Outcomes Research BACKGROUND: To identify demographic and clinical factors associated with psychological and behavioral functioning (PBF) in people with type 2 diabetes living in France. METHODS: In March 2002, approximately 10,000 adults, who had been reimbursed for at least one hypoglycemic treatment or insulin dose during the last quarter of 2001, received a questionnaire about their health status and PBF (3,646 responders). For this analysis, the 3,090 persons with type 2 diabetes, aged 18-85 years old were selected. PBF was measured with the adapted version of the Diabetes Health Profile for people with type 2 diabetes. This permitted the calculation of three functional scores - psychological distress (PD), barriers to activity (BA), and disinhibited eating (DE) - from 0 (worst) to 100 (best). RESULTS: Major negative associations were observed with PBF for microvascular complications (a difference of 6.7 in the BA score between persons with and without microvascular complications) and severe hypoglycemia (difference of 7.9 in the BA score), insulin treatment (-8.5 & -9.5 in the PD & BA scores respectively, as compared to treatment with oral hypoglycemic agents), non-adherence to treatment (-12.3 in the DE score for persons forgetting their weekly treatment), increasing weight (-8.5 & -9.7 in the PD & DE scores respectively, as compared to stable weight), at least one psychiatrist visit in 2001 (-8.9 in the DE score), and universal medical insurance coverage (-7.9 in the PD score) (due to low income). CONCLUSION: Prevention and management of microvascular complications or adherence to treatment (modifiable factors) could be essential to preserving or improving PBF among people with type 2 diabetes. A specific approach to type 2 diabetes management may be required in groups with a low socioeconomic profile (particularly people with universal medical insurance coverage), or other non modifiable factors. BioMed Central 2010-11-02 /pmc/articles/PMC2991282/ /pubmed/21044345 http://dx.doi.org/10.1186/1477-7525-8-124 Text en Copyright ©2010 Boini et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Boini, Stephanie
Erpelding, Marie-Line
Fagot-Campagna, Anne
Mesbah, Mounir
Chwalow, Judith
Penfornis, Alfred
Coliche, Vincent
Mollet, Etienne
Meadows, Keith
Briançon, Serge
Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France
title Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France
title_full Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France
title_fullStr Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France
title_full_unstemmed Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France
title_short Factors associated with psychological and behavioral functioning in people with type 2 diabetes living in France
title_sort factors associated with psychological and behavioral functioning in people with type 2 diabetes living in france
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991282/
https://www.ncbi.nlm.nih.gov/pubmed/21044345
http://dx.doi.org/10.1186/1477-7525-8-124
work_keys_str_mv AT boinistephanie factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance
AT erpeldingmarieline factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance
AT fagotcampagnaanne factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance
AT mesbahmounir factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance
AT chwalowjudith factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance
AT penfornisalfred factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance
AT colichevincent factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance
AT molletetienne factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance
AT meadowskeith factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance
AT brianconserge factorsassociatedwithpsychologicalandbehavioralfunctioninginpeoplewithtype2diabeteslivinginfrance